Sterol regulatory element-binding proteins (SREBPs) are a family of transcription factors that regulate lipid homoeostasis. Three SREBP isoforms control the expression of more than 30 genes required for the biosynthesis of cholesterol, fatty acids, triacylglycerols and phospholipids. The unique regulation and activation properties of each SREBP isoform facilitates the co-ordinate regulation of all essential lipid building blocks required for cell membranes as well as for very-lowdensity lipoprotein formation in hepatocytes.
Introduction
Cellular cholesterol and fatty acid homoeostasis are regulated by three sterol regulatory elementbinding protein (SREBP) isoforms, designated SREBP-la, SREBP-lc and SREBP-2 [1, 2] . SREBP-la and -1c are derived from a single gene located on human chromosome 17pl1.2 through the use of alternative transcription start sites that produce alternative forms of exon 1 [l] . SREBP-2 is derived from a second gene located on human chromosome 22ql3.
When cells require lipids, SREBPs transcriptionally activate a cascade of enzymes required for endogenous cholesterol, fatty acid, triacylglycerol and phospholipid synthesis. This review will focus on the regulation of each SREBP isoform and how the actions of each SREBP isoform enable cells to tightly regulate lipid homoeostasis.
SREBP structure and activation
SREBPs belong to the basic-helix-loop-helixleucine zipper (bHLH-Zip) family of transcrip- tion factors, but unlike other bHLH-Zip family members they are synthesized as approx. 11 50-amino-acid precursors bound to the endoplasmic reticulum (ER) [l] . SREBP precursors are organized into the following domains : (i) an N-terminal approx. 500-amino-acid domain containing the bHLH-Zip region, (ii) two hydrophobic transmembrane-spanning segments interrupted by a short, approx. 30-amino-acid, segment that projects into the lumen of the ER, and (iii) an approx. 590-amino-acid C-terminal segment regulatory domain. T o be active, the N-terminal segment of SREBPs, designated the nuclear form (nSREBP), must be released from the membrane so that it can translocate to the nucleus of the cell. nSREBPs are generated by a two-step cleavage process that requires at least three proteins in addition to SREBPs (Figure 1) [3]. The first protein, SREBP cleavage-activating protein (SCAP), serves as both an escort protein and a sterol-sensor. SCAP is anchored to the ER by eight membrane-spanning domains, five of which are important for sterol-sensing [1, 3] . The Cterminal domain of SCAP contains a hydrophilic region that resembles a WD-40 repeat. This region mediates the interaction with the C-terminal domain of SREBPs [1, 3] . When the cellular demand for lipids is increased, SCAP senses this need and escorts SREBPs from the ER to the Golgi. In the Golgi, the Site-1 protease, a membrane-bound subtilisin-like serine protease, cleaves SREBPs in the hydrophilic luminal loop (Figure 1) [3]. The second proteolytic cleavage occurs via the Site-2 protease, a zinc metalloproteinase that cleaves SREBPs in the first transmembrane segment, which releases the N-terminal segment of SREBPs from the membrane. The mechanism by which SCAP senses cellular sterol levels and regulates the movement of the SCAP-SREBP complex from the ER to the Golgi is unknown.
SREBP isoform function
Three SREBP isoforms have been identified and characterized in mammalian cells [l] . The relative abundance of each isoform differs in cultured cells and adult animal tissues. In most cultured cells, the predominant SREBP isoform is SREBP-la [4] . In most animal tissues, SREBP-lc is approx. 10-fold more abundant than SREBP-la and approx. twice as abundant as .
T h e transcriptional activation properties of each SREBP isoform have been delineated in vitro and in vivo [5, 6] . All SREBP isoforms can activate an entire cascade of enzymes in the cholesterol and fatty acid biosynthetic pathways if expressed at superphysiological levels. SREBP-1 a is a potent transcriptional activator of all SREBP-responsive genes owing to the long transactivation domain encoded by exon l a ; however, SREBP-la is constitutively expressed at very low levels in most animal tissues. This suggests that SREBP-la may be responsible for maintaining basal levels of cholesterol and fatty acid synthesis in vivo. SREBP-1 c has a shorter transactivation domain that reduces its overall activation strength and imparts its selectivity towards activating genes involved in lipogenesis [6] . SREBP-2, like SREBP-1 a, has a long transactivation domain, but its activity is more restricted to regulating genes involved in cholesterol homoeostasis [6] . Figure 2 shows the identified SREBPregulated genes in italics [6, 7] . Common to both pathways is acetyl-CoA, the precursor for cholesterol and fatty acids. Acetyl-CoA is generated by ATP-citrate lyase and acetyl-CoA synthetase. ATP-citrate lyase produces acetyl-CoA from citrate and acetyl-CoA synthetase generates acetyl-CoA from acetate. Both enzymes are transcriptionally activated by all SREBPs [6, 7] .
Studies carried out in cultured cells, and in genetically manipulated mice, have demonstrated that SREBP-lc preferentially controls genes involved in lipogenesis [5, 6] . Transgenic mice that overexpress nSREBP-lc in liver manifest a 6-fold increase in hepatic fatty acid synthesis with no changes in cholesterol biosynthesis. Conversely, knockout mice that lack SREBP-lc have an approx. 50% reduction in the expression of all fatty acid biosynthetic enzymes and a corresponding approx. 50 yo reduction in overall hepatic fatty acid biosynthesis [6] . Genes in the fatty acid biosynthetic pathway that are regulated in SREBP-1 c transgenic and knockout mice include those encoding acetyl-CoA carboxylase and fatty acid synthase, the cytosolic enzymes responsible for the synthesis of saturated fatty acids up to 16 carbons in length. In addition, SREBP-lc preferentially activates the long-chain fatty acyl elongase, a microsomal enzyme that carries out the rate-limiting condensation reaction required . the synthesis of polyunsaturated fatty acids. Polyunsaturated fatty acids are synthesized from linoleic acid (18:2, n -6 ) and linolenic acid (18:3, n -3 ) through a series of elongation and de-
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SREBP isoform regulation
A'-desaturase enzymes carry out the desaturation reactions and both genes are transcriptionally activated by SREBP-1 isoforms [8]. Interestingly, polyunsaturated fatty acids are also potent negative regulators of SREBP-1 c expression through mechanisms discussed below. SREBP-2 preferentially activates genes responsible for cholesterol synthesis and uptake.
that alter the cleavage of the precursor, and by mechanisms that regulate gene transcription. Post-transcriptional regulation involves sterolmediated suppression of SREBP cleavage, which occurs by inhibiting the movement of the SCAP-SREBP complex from the ER to the Golgi (Figure 1 ). This form of regulation blocks all SREBP isoform activation in cells cultured in the presIdentified cholesterol biosynthetic enzymes directly regulated by SREBP-2 are shown in Fig Transcriptional regulation provides a mechanism to independently regulate SREBP isoform expression. One transcriptional mechanism shared by SREBP-lc and SREBP-2 involves a feedforward regulation, mediated by sterol response elements present in the promoters of each gene [9, 10] . This establishes a feed-forward loop, whereby nSREBPs activate the transcription of their own genes. At least three additional factors regulate the transcription of SREBP-lc: liver Xactivated receptors (LXRs), insulin and glucagon.
LXR a and /? are nuclear receptors that form heterodimers with retinoid X receptors and are activated by oxysterols [ll] . T h e SREBP-lc promoter contains an LXR binding site that activates SREBP-1 c transcription in the presence of LXR agonists [12] . Mice that lack LXR ( a and p) have reduced levels of SREBP-lc and its lipogenic target enzymes in liver [12] . T h e LXRmediated induction of SREBP-lc provides a mechanism to induce oleate synthesis when sterol levels are elevated in the cell. Oleate is the preferred fatty acid for the synthesis of cholesteryl esters, which are necessary for the storage of cholesterol.
LXR-mediated regulation of SREBP-lc is also one mechanism by which unsaturated fatty acids suppress fatty acid synthesis. Unsaturated fatty acids competitively block LXR activation of SREBP-lc expression by antagonizing the activation of LXR by its endogenous ligands in vitro [13] . In vivo, rodents fed on diets enriched with polyunsaturated fatty acids manifest reduced SREBP-lc mRNA expression and low rates of lipogenesis in liver [14] . These effects may contribute to the ability of polyunsaturated fatty acids to lower plasma triacylglycerol levels.
Insulin acts to stimulate fatty acid synthesis in liver. In vitro and in vivo evidence suggests that insulin's ability to stimulate fatty acid synthesis is mediated by SREBP-lc. In vitro, culturing rat primary hepatocytes in the presence of insulin increases the amount of SREBP-lc mRNA in parallel with the mRNAs of its target genes [15] . If a dominant-negative form of SREBP-lc is expressed in primary hepatocytes, insulin's ability to induce lipogenesis is blocked [16] . T h e action of insulin is opposed by glucagon, which acts by raising CAMP. If hepatocytes are incubated with glucagon or dibutyryl CAMP, the mRNAs for SREBP-lc and its target genes are reduced [16] .
In vivo, the total amount of SREBP-lc in liver and adipose tissue is reduced by fasting (low insulin/high glucagon) and elevated by refeeding (high insulin/low glucagon) [6] . T h e mRNA levels of SREBP-lc target genes parallel the changes in SREBP-lc expression. nSREBP-1 c overexpression in liver prevents the reduction in lipogenic mRNAs that normally follows a fall in plasma insulin levels. Conversely, knockout mice that have a selective deletion in nSREBP-lc [17] or both SREBP-1 isoforms [18] exhibit a marked decrease in the insulin-induced stimulation of hepatic lipogenic gene expression that normally occurs after fasting/refeeding. Taken together, the above evidence suggests that SREBP-lc mediates insulin's lipogenic actions in liver.
Conclusion
SREBPs are transcriptional regulators of lipid metabolism within the cell. T o date, in vivo and in vitro studies suggest that SREBP-2 is absolutely required for the normal cholesterol homeostasis. SREBP-lc is required to maintain basal levels of fatty acid synthesis, and it mediates the insulinand LXR-induced transcriptional activation of fatty acid synthesis. However, additional factors not discussed in this review, such as upstream stimulatory factors 1 and 2, LXR, and the carbohydrate response element-binding protein, can independently contribute to the regulation of lipogenic gene expression 119-211. Therefore, SREBP-lc is one important component of a more complex system that regulates overall rates of lipogenesis in the cell. 
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